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Background: Bleeding is the most common complication following PCI and is associated with increased morbidity and health care costs. However, 
the impact of major bleeding on in-hospital mortality is unclear.
Methods: Data from 2,763,506 procedures in the CathPCI Registry® between 2004 and 2011 were analyzed. The population attributable risk 
(PAR) for mortality related to major bleeding was calculated after adjustment for baseline mortality risk. Patients with bleeding were then propensity 
matched to a non-bleeding cohort in a 4:1 fashion, to correct for baseline clinical variables, bleeding risk and mortality risk. In-hospital mortality 
was assessed in the total cohort, and in subgroups according to bleeding site and bleeding risk.
Results: The PAR for mortality related to major bleeding was 13% in the entire cohort. The propensity matched population consisted of 49,418 
patients with a major bleed and 197,160 controls. Bleeding was associated with increased in-hospital mortality in the overall cohort, in patients 
with access-site and non-access-site bleeding, and in all subgroups of bleeding risk (Table 1). The number of bleeding events associated with one 
in-hospital death (number needed to harm) varied depending on bleeding site and bleeding risk.
Conclusion: In the CathPCI Registry, 13% of in-hospital mortality was directly attributable to major bleeding. The number needed to harm was as 
low as 19 in high-risk patients or patients with non-access-site bleeding.
Table 1 
Mortality
p-value NNH*
Bleed No Bleed
Total Cohort 5.48% 1.73% <0.001 27
Site of Bleed
Access site 3.47% 1.30% <0.001 46
Non-access site 7.25% 2.12% <0.001 19
Bleeding Risk
Low (<1%) 1.80% 0.11% <0.001 59
Intermediate (1-3%) 3.31% 0.55% <0.001 36
High (>3%) 8.49% 3.28% <0.001 19
*NNH = number needed to harm
